Soleus Capital Management, L.P. Teva Pharmaceutical Industries LTD Transaction History

Soleus Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $37.1 Million - $50.5 Million	-2,899,941 Reduced 83.18%	586,499 $9.53 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $22.2 Million - $30 Million	-2,078,000 Reduced 37.34%	3,486,440 $49.2 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $3.96 Million - $5.18 Million	-487,724 Reduced 8.06%	5,564,440 $58.1 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $13.5 Million - $19.3 Million	1,802,164 Added 42.4%	6,052,164 $61.7 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $30.6 Million - $40.2 Million	4,250,000 New	4,250,000 $32 Million

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.